H. Lundbeck A/S
H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat maj… Read more
H. Lundbeck A/S (HLBBF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.014x
Based on the latest financial reports, H. Lundbeck A/S (HLBBF) has a cash flow conversion efficiency ratio of 0.014x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($337.23 Million) by net assets ($24.85 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
H. Lundbeck A/S - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how H. Lundbeck A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
H. Lundbeck A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of H. Lundbeck A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Porto Seguro S.A
SA:PSSA3
|
0.075x |
|
HKBN Ltd
PINK:HKBNY
|
0.279x |
|
Eurocommercial Properties N.V.
AS:ECMPA
|
0.020x |
|
Anhui XDLK Microsystem Corp. Ltd. A
SHG:688582
|
N/A |
|
Wuhan PS Information Tech
SHE:300184
|
0.011x |
|
Clas Ohlson AB (publ)
ST:CLAS-B
|
0.033x |
|
DIC Corporation
F:DPN
|
0.038x |
|
Northeast Securities Co Ltd
SHE:000686
|
-0.401x |
Annual Cash Flow Conversion Efficiency for H. Lundbeck A/S (2004–2025)
The table below shows the annual cash flow conversion efficiency of H. Lundbeck A/S from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $24.85 Billion | $4.89 Billion | 0.197x | +47.90% |
| 2024-12-31 | $25.01 Billion | $3.33 Billion | 0.133x | -28.14% |
| 2023-12-31 | $22.05 Billion | $4.08 Billion | 0.185x | +9.28% |
| 2022-12-31 | $20.78 Billion | $3.52 Billion | 0.169x | +36.25% |
| 2021-12-31 | $18.28 Billion | $2.27 Billion | 0.124x | -45.02% |
| 2020-12-31 | $16.97 Billion | $3.84 Billion | 0.226x | +26.11% |
| 2019-12-31 | $14.55 Billion | $2.61 Billion | 0.179x | -57.29% |
| 2018-12-31 | $14.25 Billion | $5.98 Billion | 0.420x | +26.38% |
| 2017-12-31 | $12.18 Billion | $4.04 Billion | 0.332x | +2.98% |
| 2016-12-31 | $9.69 Billion | $3.13 Billion | 0.322x | +1338.01% |
| 2015-12-31 | $8.79 Billion | $197.00 Million | 0.022x | -81.16% |
| 2014-12-31 | $13.53 Billion | $1.61 Billion | 0.119x | -57.32% |
| 2013-12-31 | $13.48 Billion | $3.76 Billion | 0.279x | +74.29% |
| 2012-12-31 | $13.20 Billion | $2.11 Billion | 0.160x | -43.59% |
| 2011-12-31 | $12.78 Billion | $3.62 Billion | 0.284x | -3.37% |
| 2010-12-31 | $11.12 Billion | $3.27 Billion | 0.294x | -14.82% |
| 2009-12-31 | $8.80 Billion | $3.03 Billion | 0.345x | -5.88% |
| 2008-12-31 | $7.59 Billion | $2.78 Billion | 0.366x | -2.72% |
| 2007-12-31 | $7.18 Billion | $2.70 Billion | 0.376x | +82.69% |
| 2006-12-31 | $6.76 Billion | $1.39 Billion | 0.206x | -25.47% |
| 2005-12-31 | $7.49 Billion | $2.07 Billion | 0.277x | -19.06% |
| 2004-12-31 | $7.84 Billion | $2.68 Billion | 0.342x | -- |